Cargando…

Will whole-genome sequencing become the first-line genetic analysis for male infertility in the near future?

Whereas the initially strategy for the genetic analysis of male infertility was based on a candidate gene approach, the development of next-generation sequencing technologies (such as whole-exome sequencing (WES)) provides an opportunity to analyze many genes in a single procedure. In order to recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghieh, Farah, Barbotin, Anne-Laure, Leroy, Clara, Marcelli, François, Swierkowsky-Blanchard, Nelly, Serazin, Valérie, Mandon-Pepin, Béatrice, Vialard, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375164/
https://www.ncbi.nlm.nih.gov/pubmed/34407766
http://dx.doi.org/10.1186/s12610-021-00138-4
Descripción
Sumario:Whereas the initially strategy for the genetic analysis of male infertility was based on a candidate gene approach, the development of next-generation sequencing technologies (such as whole-exome sequencing (WES)) provides an opportunity to analyze many genes in a single procedure. In order to recommend WES or whole-genome sequencing (WGS) after genetic counselling, an objective evaluation of the current genetic screening strategy for male infertility is required, even if, at present, we have to take into consideration the complexity of such a procedure, not discussed in this commentary.